Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacological Management of Hypertrophic Cardiomyopathy: From Bench to Bedside
Chiara Palandri, Lorenzo Santini, Alessia Argirò, et al.
Drugs (2022) Vol. 82, Iss. 8, pp. 889-912
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Logic-based machine learning predicts how escitalopram attenuates cardiomyocyte hypertrophy
Taylor G. Eggertsen, Joshua G. Travers, Elizabeth J. Hardy, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 10
Open Access | Times Cited: 1
Revisiting Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Current Practice and Novel Perspectives
A Ottaviani, Davide Mansour, Lorenzo V. Molinari, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 17, pp. 5710-5710
Open Access | Times Cited: 19
Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
James A. Coleman, Rubén Doste, Matteo Beltrami, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
A microstructure-based finite element model of the human left ventricle for simulating the trans-scale myocardial mechanical behaviors
Taiwei Liu, Fuyou Liang
Mechanics of Materials (2025), pp. 105273-105273
Closed Access
Hypertrophic Cardiomyopathy Through the Lens of Mitochondria
Tatiana V. Kirichenko, Ivan V. Zhivodernikov, Maria A. Kozlova, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 591-591
Open Access
Mechanism based therapies enable personalised treatment of hypertrophic cardiomyopathy
Francesca Margara, Yiangos Psaras, Zhinuo Jenny Wang, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 19
An Electromechanical Model-Based Study on the Dosage Effects of Ranolazine in Treating Failing HCM Cardiomyocyte
Taiwei Liu, Mi Zhou, Fuyou Liang
Cellular and Molecular Bioengineering (2025)
Closed Access
Exploring and Expanding Secondary Findings Through Exome Sequencing in the Turkish Population
Mehmet Berkay Akcan, Canan Ceylan Köse, Kübra Müge Çelik, et al.
Annals of Human Genetics (2025)
Closed Access
Recent Clinical Updates of Hypertrophic Cardiomyopathy and Future Therapeutic Strategies
Mengya Zhao, Xianzhen He, Xinwen Min, et al.
Reviews in Cardiovascular Medicine (2025) Vol. 26, Iss. 2
Open Access
Advancements in the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
妞妞 牟
Advances in Clinical Medicine (2025) Vol. 15, Iss. 03, pp. 108-115
Closed Access
Modeling cardiomyocyte signaling and metabolism predicts genotype-to-phenotype mechanisms in hypertrophic cardiomyopathy
Ali Khalilimeybodi, Jeffrey J. Saucerman, Padmini Rangamani
Computers in Biology and Medicine (2024) Vol. 175, pp. 108499-108499
Open Access | Times Cited: 3
Hypertrophic Cardiomyopathy Diagnosis and Treatment in High- and Low-Income Countries: A Narrative Review
Ernesto Calderón Martinez, Nancy Yesenia Ortiz-Garcia, Domenica A Herrera Hernandez, et al.
Cureus (2023)
Open Access | Times Cited: 8
Evaluation of Tyrosine Kinase Inhibitors Loaded Injectable Hydrogels for Improving Connexin43 Gap Junction Intercellular Communication
L S Zheng, Wen Shi, Bo Liu, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 2, pp. 1985-1998
Open Access | Times Cited: 2
Computational modeling of electromechanical coupling in human cardiomyocyte applied to study hypertrophic cardiomyopathy and its drug response
Taiwei Liu, Xuanyu Li, Yue Wang, et al.
Computer Methods and Programs in Biomedicine (2023) Vol. 231, pp. 107372-107372
Closed Access | Times Cited: 6
Mechanisms and prognostic impact of myocardial ischaemia in hypertrophic cardiomyopathy
James A. Coleman, Zakariye Ashkir, Betty Raman, et al.
The International Journal of Cardiovascular Imaging (2023) Vol. 39, Iss. 10, pp. 1979-1996
Open Access | Times Cited: 6
Integrating mechanical cues with engineered platforms to explore cardiopulmonary development and disease
Donia W Ahmed, Madeline K. Eiken, Samuel J. DePalma, et al.
iScience (2023) Vol. 26, Iss. 12, pp. 108472-108472
Open Access | Times Cited: 6
Manejo Clínico da Cardiomiopatia Hipertrófica: Tratamento Farmacológico e Intervenções Cirúrgica
Eloísa Leal Silva Marim, Amanda De Andrade Gomes, Luana Laurito Batista, et al.
Brazilian Journal of Implantology and Health Sciences (2024) Vol. 6, Iss. 2, pp. 1311-1325
Open Access | Times Cited: 1
Combined Pharmacological Modulation of Translational and Transcriptional Activity Signaling Pathways as a Promising Therapeutic Approach in Children with Myocardial Changes
A. V. Каmеnshchyk, И. Ф. Беленичев, Valentyn Oksenych, et al.
Biomolecules (2024) Vol. 14, Iss. 4, pp. 477-477
Open Access | Times Cited: 1
Cell-to-cell heterogeneity in ion channel conductance impacts substrate vulnerability to arrhythmia
Taylor K. Pullinger, Eric A. Sobie
AJP Heart and Circulatory Physiology (2024) Vol. 327, Iss. 1, pp. H242-H254
Closed Access | Times Cited: 1
Mavacamten in hypertrophic obstructive cardiomyopathy: Prospects for AI integration and mitigating healthcare disparities
Samia Aziz Sulaiman, A. Saeed, A. Khatib, et al.
Current Problems in Cardiology (2024) Vol. 49, Iss. 11, pp. 102786-102786
Closed Access | Times Cited: 1
Remodelling of potassium currents underlies arrhythmic action potential prolongation under beta-adrenergic stimulation in hypertrophic cardiomyopathy
Rubén Doste, Raffaele Coppini, Alfonso Bueno‐Orovio
Journal of Molecular and Cellular Cardiology (2022) Vol. 172, pp. 120-131
Open Access | Times Cited: 6
Comparing the efficacy and safety of medications in adults with hypertrophic cardiomyopathy: a systematic review and network meta-analysis
Keying Mi, Sijia Wu, Chanyuan Lv, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 3
Obstructive Hypertrophic Cardiomyopathy: A Review of New Therapies
Nandini Mehra, Adel Hajj Ali, Milind Y. Desai
Future Cardiology (2023) Vol. 19, Iss. 13, pp. 661-670
Closed Access | Times Cited: 3
Multi-modality management of hypertrophic cardiomyopathy
Shiavax J. Rao, Shaikh B. Iqbal, Arjun Kanwal, et al.
Hospital Practice (2023) Vol. 51, Iss. 1, pp. 2-11
Closed Access | Times Cited: 3
Current and emerging pharmacotherapy for the management of hypertrophic cardiomyopathy
Akiva Rosenzveig, Neil K. Garg, Shiavax J. Rao, et al.
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 12, pp. 1349-1360
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top